刘烈华

研究方向：糖尿病早期短程胰岛素强化治疗； 主要教育和工作经历： 工作经历： 2008.7-2012.12 中山大学附属第一医院内分泌科住院医师 2013.1-2019.2中山大学附属第一医院内分泌科主治医师 2019.3至今 中山大学附属第一医院内分泌科副主任医师 教育经历 2001.9-2008.6 中山大学中山医学院七年制硕士 2012.9-2015.5 中山大学临床医学博士 2013.11-2014.10 瑞典隆德大学访问学者 社会兼职： 广东省医师协会内分泌学分会委员 广东省健康管理学会代谢与内分泌专业委员会常委 Diabetes care中文版编委 论著： 1.Liu L, Ke W, Wan X, Zhang P, Cao X, Deng W, Li Y. Insulin requirement profiles of short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes and its association with long-term glycemic remission. Diabetes Res Clin Pract. 2015. 108(2): 250-7. 2.Liu L, Omar B, Marchetti P, Ahren B. Dipeptidyl peptidase-4 (DPP-4): Localization and activity in human and rodent islets. Biochem Biophys Res Commun. 2014. 453(3): 398-404. 3.Ke W, Liu L, Liu J, Chen A, Deng W, Zhang P, Cao X, Liao Z, Xiao H, Liu J, Li Y. Effects of Liraglutide Combined with Short-Term Continuous Subctaneous Insulin Infusion on Glycemic Control and Beta Cell Function in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Pilot Study. J Diabetes Res. 2016. 2016: 6839735. 4.Liu L, Yang S, Liu J, Li H, Liu J, Cao X, Xiao H, Li Y. Fasting Plasma Glucose Indicates Reversibility of the Acute Insulin Response after Short-Term Intensive Insulin Therapy in Patients with Various Duration of Type 2 Diabetes. J Diabetes Res. 2018. 2018: 9423965. 5.Liu L, Wan X, Liu J, Huang Z, Cao X, Li Y. Increased 1,5-anhydroglucitol predicts glycemic remission in patients with newly diagnosed type 2 diabetes treated with short-term intensive insulin therapy. Diabetes Technol Ther. 2012. 14(9): 756-61. 6.Liu L, Liu J, Xu L, Ke W, Wan X, Li H, He X, Wang L, Cao X, Xiao H, Li Y. Lower mean blood glucose during short-term intensive insulin therapy is associated with long-term glycemic remission in patients with newly diagnosed type 2 diabetes: Evidence-based recommendations for standardization. J Diabetes Investig. 2018. 9(4): 908-916. 7.刘烈华. 基础胰岛素联合口服降糖药控糖不佳时的治疗选择. 糖尿病天地. 2016. 10(09): 419-421. 8.刘烈华, 李延兵. 细节决定成败—论新诊断2...

从事内分泌及代谢病临床及科研十余年，医疗专长为糖尿病及其并发症的规范化诊治，尤擅新诊断患者或口服药失效患者短程强化治疗诱导方案简化。对于甲状腺功能亢进/减退、甲状腺结节、甲状腺炎、肾上腺及垂体下丘脑疾病亦有较丰富的临床经验。